Skip to main content
logo
GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
23.41
-0.43 (-1.80%)
Sep 28, 2026, 3:43 PM EDT - Market open

GH Research Earnings Call Transcripts

Fiscal Year 2025

  • Status Update

    GH001 showed rapid, robust, and sustained efficacy in TRD, with a high remission rate and favorable safety profile. Long-term data indicate durable remission with infrequent treatments and fewer clinic visits compared to current standards.

    Read full transcript →